It is only sensitive to hemolytic streptococcus and pneumococcus, sensitive to most gram-negative bacteria, has a strong tolerance to beta-lactamase, and the ability to induce beta-lactamase is very low, which is not easy to induce bacteria to develop drug resistance. The molecular formula is C25H26N9NaO8S2, CAS number is 62893-20-3.

Market Analysis and Insights: Global Cefoperazone Sodium Market
The global Cefoperazone Sodium market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.

Global Cefoperazone Sodium Scope and Market Size
The global Cefoperazone Sodium market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cefoperazone Sodium market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Purity ≥ 98 %
Purity ≥ 99 %

Segment by Application
Cefoperazone Sodium Injection
Other

The Cefoperazone Sodium market is analysed and market size information is provided by regions (countries). Segment by Application, the Cefoperazone Sodium market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
ACS Dobfar
Sterile India
Nectar Lifesciences
Qilu Pharmaceutial
Hangzhou Viwa
Sinopharm Weiqida Pharmaceutical
United Laboratories International Holdings
Dawnrays
Hebei Hejia Pharmaceutical
Luoxin Pharmaceutical
Titan Pharmaceutical
Henan Kangda Pharma